Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesYD Bio Ltd

YD Bio Ltd

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
6.19 USD -0.99 ( 13.79%)
Last update at 2026-11-06T21:00:00Z
VOLUME
206945
Market Cap
279.78M

Momentum Score

…

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
5.87
Low
7.45
High
52 Week Price Range
1.70
Low
22.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
7.18
Dividend Yield
-
Revenue TTM
0.51M
Revenue Per Share
0.47
Gross Profit TTM
0.16M
Debt / Equity
-0.00
ROE
-42.69%
Net Debt
-6.00M
ROCE
-68.50%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -8.31M -1.39M 0.02M 3.79M 8.70M
Net income -8.31M -1.41M 0.01M 3.79M 8.70M
Selling general administrative 3.82M 1.12M 0.15M - -
Selling and marketing expenses - 0.00M 0.01M - -
Gross profit -0.04M 0.16M 0.15M - -
Reconciled depreciation 0.21M 0.10M 0.00M - -
Ebit -8.31M -1.39M 0.02M - -
Ebitda -8.10M -1.28M 0.02M 3.79M 8.70M
Depreciation and amortization 0.21M 0.10M 0.00M - -
Operating income -5.27M -1.46M -0.01M -2.32M -1.72M
Other operating expenses 5.87M 1.97M 0.36M 2.32M 1.72M
Interest expense 0.00M 0.00M 0.00M - -
Tax provision -0.00M 0.03M 0.00M - -
Interest income 0.08M 0.01M 0.00M - -
Net interest income 0.08M 0.01M -0.00M - -
Income tax expense -0.00M 0.03M 0.00M 0.00M -
Total revenue 0.60M 0.51M 0.35M - -
Total operating expenses 5.23M 1.62M 0.16M 2.32M 1.72M
Cost of revenue 0.64M 0.36M 0.20M - -
Total other income expense net -3.04M 0.08M 0.03M 6.11M 10.43M
Net income from continuing ops -8.31M -1.41M 0.01M - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 13.78M 6.86M 0.32M 17.93M 118.06M
Intangible assets 2.61M 2.68M - - -
Other current assets 1.07M 0.04M 0.02M 0.17M 0.12M
Total liab 16.64M 0.27M 0.30M 6.74M 9.11M
Total stockholder equity -2.86M 6.59M 0.02M 11.20M 108.96M
Other current liab 1.19M 0.22M 0.23M 5.55M 2.00M
Common stock 0.01M 0.14M 0.11M 17.73M 115.00M
Capital stock 0.01M 0.14M 0.11M - -
Retained earnings -10.24M -1.93M -0.52M -6.53M -6.52M
Other assets 0.00M - - - -
Cash 6.01M 3.13M 0.09M 0.01M 0.01M
Total current liabilities 1.64M 0.26M 0.30M 5.55M 2.00M
Current deferred revenue 0.03M - - - -
Net debt -6.00M -3.11M -0.04M -0.01M -0.01M
Short term debt 0.01M 0.02M 0.05M - -
Short long term debt - 0.00M 0.03M - -
Short long term debt total 0.01M 0.02M 0.05M - -
Other stockholder equity 7.16M 8.33M 0.39M - 0.48M
Total current assets 9.67M 3.47M 0.27M 0.20M 0.13M
Long term investments - 0.00M 0.01M - -
Net receivables 0.71M 0.26M 0.10M 0.02M -
Inventory 1.88M 0.04M 0.07M - -
Accounts payable 0.41M 0.03M 0.02M - -
Accumulated other comprehensive income 0.21M 0.05M 0.05M - -
Non currrent assets other 1.43M -9.90M - - -
Non current assets total 4.11M 3.40M 0.05M 17.73M 117.93M
Capital lease obligations 0.01M 0.02M 0.01M - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.00M -2.90M -0.00M - -
Total cashflows from investing activities -1.44M -2.90M -0.00M 100.38M -1.15M
Net borrowings 0.00M -0.03M -0.03M - -
Total cash from financing activities 10.87M 7.73M 0.11M -97.34M 1.15M
Net income -8.31M -1.41M 0.01M 3.79M 8.70M
Change in cash 2.88M 3.05M 0.06M 0.01M -0.69M
Begin period cash flow 3.13M 0.09M 0.03M 0.01M 0.69M
End period cash flow 6.01M 3.13M 0.09M 0.01M 0.01M
Total cash from operating activities -6.60M -1.84M -0.06M -3.02M -0.69M
Issuance of capital stock 13.20M 7.86M 0.05M - -
Depreciation 0.21M 0.10M 0.00M - -
Other cashflows from investing activities - -2.84M 0.53M 101.78M -
Change to inventory -1.84M 0.03M -0.03M - -
Change to account receivables -0.36M -0.01M -0.06M - -
Sale purchase of stock - - - -101.55M -
Other cashflows from financing activities 0.17M -0.10M 0.09M - -
Capital expenditures 1.44M 2.91M 0.00M 0.00M 0.00M
Change in working capital -1.69M -0.57M -0.13M -0.70M 0.63M
Other non cash items 3.19M 0.01M 0.05M -6.11M -10.02M
Free cash flow -8.04M -4.75M -0.06M -3.02M -0.69M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
YDES
YD Bio Ltd		 -0.99
13.79%		 6.19 - - 548.21 60.65 216.79
NVO
Novo Nordisk A/S		 0.01
0.02%		 40.31 41.58 31.15 2.13 32.99 2.11
VRTX
Vertex Pharmaceuticals Inc		 4.59
0.85%		 547.09 30.22 24.27 10.36 6.50 9.99
REGN
Regeneron Pharmaceuticals Inc		 1.45
0.16%		 904.35 29.07 20.12 7.57 3.82 6.95
ARGNF
argenx SE		 -
-%		 900.30 45.77 31.25 13.84 7.12 11.38

Profile*

YD Bio Ltd

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

No. 3, Xingnan St., Taipei, Taiwan, 115001

https://www.ydesgroup.com

Name Title Year Born
Dr. Ethan Shen Ph.D. CEO & Chairman 1977
Mr. Edmund Hen CPA, F.C.A., M.S. Chief Financial Officer 1974
Dr. Benjamin Zhang M.D. Chief Medical Officer & Director 2000

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…